A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT05536804
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 134 participants
- Sponsor
- Registry
-
NCT05536804 -
2021-005273-47
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Austria, Canada, Denmark, Mexico, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT05536804. Randomized; double masking; primary purpose treatment. Start 2023-02-08 (actual); primary completion 2026-07-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- Acronym
- TREASURE-CKD
- Condition
- Overweight
- Condition
- Obesity
- Condition
- Chronic Kidney Disease
- Condition
- Type 2 Diabetes
- Condition
- T2D
- Intervention (Drug)
- Tirzepatide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct05536804- Content hash
034880d0ed1c50f8505529b69853aeae5e52239aa108901e1265430b9bf14e2e